PRCT vs. NVO
Compare and contrast key facts about PROCEPT BioRobotics Corporation (PRCT) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PRCT or NVO.
Correlation
The correlation between PRCT and NVO is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
PRCT vs. NVO - Performance Comparison
Key characteristics
PRCT:
0.82
NVO:
-0.75
PRCT:
1.91
NVO:
-0.90
PRCT:
1.22
NVO:
0.88
PRCT:
1.64
NVO:
-0.60
PRCT:
4.76
NVO:
-1.44
PRCT:
10.71%
NVO:
19.31%
PRCT:
62.36%
NVO:
37.13%
PRCT:
-63.51%
NVO:
-71.31%
PRCT:
-28.01%
NVO:
-43.55%
Fundamentals
PRCT:
$3.87B
NVO:
$368.49B
PRCT:
-$1.96
NVO:
$2.95
PRCT:
$156.26M
NVO:
$204.72B
PRCT:
$92.16M
NVO:
$173.22B
PRCT:
-$65.56M
NVO:
$108.42B
Returns By Period
In the year-to-date period, PRCT achieves a -11.09% return, which is significantly lower than NVO's -3.95% return.
PRCT
-11.09%
-15.08%
18.17%
48.47%
N/A
N/A
NVO
-3.95%
-5.74%
-36.27%
-29.37%
22.68%
16.93%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
PRCT vs. NVO — Risk-Adjusted Performance Rank
PRCT
NVO
PRCT vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for PROCEPT BioRobotics Corporation (PRCT) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PRCT vs. NVO - Dividend Comparison
PRCT has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 1.75%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRCT PROCEPT BioRobotics Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 1.75% | 1.68% | 1.00% | 1.20% | 1.34% | 1.86% | 2.14% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% |
Drawdowns
PRCT vs. NVO - Drawdown Comparison
The maximum PRCT drawdown since its inception was -63.51%, smaller than the maximum NVO drawdown of -71.31%. Use the drawdown chart below to compare losses from any high point for PRCT and NVO. For additional features, visit the drawdowns tool.
Volatility
PRCT vs. NVO - Volatility Comparison
PROCEPT BioRobotics Corporation (PRCT) has a higher volatility of 14.61% compared to Novo Nordisk A/S (NVO) at 13.26%. This indicates that PRCT's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
PRCT vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between PROCEPT BioRobotics Corporation and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities